Last updated on April 2016

AdaptResponse Clinical Trial

Brief description of study

The purpose of this clinical study is to test the hypothesis that market released Cardiac Resynchronization Therapy (CRT) devices which contain the AdaptivCRT® (aCRT) algorithm have a superior outcome compared to standard CRT devices in CRT indicated patients with normal atrio-ventricular (AV) conduction and left bundle branch block (LBBB).

Clinical Study Identifier: NCT02205359

Contact Investigators or Research Sites near you

Start Over

AdaptResponse Trial Leader

Austin Hospital
Heidelberg, Australia
  Connect »